MolMed on Superquark Rai1

News & Events

Stay update

MolMed on Superquark Rai1 ▾

MolMed on Superquark Rai1

Tonight, Wednesday 7 August, the popular TV scientific magazine of Rai1 channel, will explain what CAR-T therapies are, also through a trip into MolMed's facilities, among the few in the world with a GMP authorization for the development and manufacturing of Cell & Gene advanced therapies. The episode can be followed live on Rai1 TV at 9.25 pm, or in streaming on RaiPlay channel, at the page dedicated to the famous program directed by Piero Angela.

https://www.raiplay.it/video/2019/08/Superquark-Biotech-italiano-1756b072-8cb4-4443-ac03-156bae29f146.html

Subscribe to press releases

Contacts

Investor Relations & Communication Manager
Phone: +39 02 21277.205
E-mail: investor.relations@molmed.com

Investors

Dear Users, we would like to inform you that, as of 30 September, AGC Biologics S.p.A. (formerly MolMed S.p.A.) is no longer listed on the Milan Stock Exchange and has become part of the AGC Biologics Group. For any information on the company and the group, you are kindly invited to consult the websitewww.agcbio.com.
The contents present on this portal (www.molmed.com) are updated until the date of September 30, 2020 and will be available for the time frame foreseen by applicable regulations.
In addition, the "work with us" section is still active, while the contact details are no longer accessible.

News & Events

Stay update

MolMed on Superquark Rai1 ▾

MolMed on Superquark Rai1

Subscribe to press releases

About us

About us ▾

Pipeline

Pipeline ▾

GMP Solutions

GMP Solutions ▾

Investors

Investors ▾

Governance

Governance ▾

News & Events

News ▾